Next 10 |
2024-09-25 04:56:00 ET Investors looking for stocks that can provide dramatic gains found what they were looking for with a pair of cancer drug developers. From the end of 2023 through the closing bell on Sept. 23, shares of Summit Therapeutics and Instil Bio marched over 700% higher. ...
2024-09-19 14:33:15 ET Summary Summit Therapeutics' ivonescimab shows improved efficacy over Merck's Keytruda in Phase III trials, targeting both PD-1 and VEGF, potentially expanding the PD-1 inhibitor market. Despite risks, Summit's promising data and significant insider investme...
2024-09-18 09:30:24 ET Summary Key oncology conferences like ASCO, ASH, and ESMO drive investment-informing clinical research, with recent ESMO 2024 data highlighting significant advancements in immunotherapy. Merck's pembrolizumab continues to show strong survival benefits across...
2024-09-17 04:24:00 ET September has been an exciting time for investors with their fingers on the pulse of cancer drug development. In a nutshell, it looks like the world's top-selling cancer therapy could have a serious competitor. Sales of Keytruda from Merck reached $25 billion ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.5% to $116.106 on volume of 42,019,244 shares Bone Biologics Corp (BBLG) rose 83.8% to $1.47 on volume of 28,279,214 shares Zentalis Pharmaceuticals Inc. (ZNTL) rose 42.7% to $4.625 on volume of 25,143,2...
Global registrational strategy in first-line non-squamous and squamous non-small cell lung cancer (NSCLC) Global registrational strategy in first-line triple-negative breast cancer (TNBC) Initiation of Phase 1b/2 IMM2510/SYN-2510 + chemotherapy combination in first-line NSCLC an...
2024-09-14 04:56:00 ET If you're an investor looking for stocks that can make dramatic gains in a short amount of time, you may have noticed a small-cap biopharmaceutical company called Instil Bio (NASDAQ: TIL) has been rocketing higher. From Sept. 6 through Sept. 12, shares of ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 0.0% to $119.1 on volume of 236,722,246 shares 22nd Century Group Inc (XXII) rose 27.1% to $0.3422 on volume of 182,585,058 shares Immuneering Corporation (IMRX) rose 41.3% to $2.02 on volume of 136,172,11...
2024-09-13 15:22:20 ET More on BioNTech, Merck, etc. Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements BioNTech's Low Valuation, Many Shots On Goal Make It A Buy Summit Therapeutics: Positive Data Leads To Targeting Of Other NSCLC Subpopulation ...
2024-09-13 15:00:43 ET More on the markets SPY: CPI Tailwinds Already Priced In The Curtain Is About To Be Lifted On A Market Implosion Or Explosion How To Allocate 10 Dividend Picks To Strategically Enhance Your S&P 500 ETF (SPY) Pantheon Macroeconomics ...
News, Short Squeeze, Breakout and More Instantly...
2024-09-25 04:56:00 ET Investors looking for stocks that can provide dramatic gains found what they were looking for with a pair of cancer drug developers. From the end of 2023 through the closing bell on Sept. 23, shares of Summit Therapeutics and Instil Bio marched over 700% higher. ...
2024-09-17 04:24:00 ET September has been an exciting time for investors with their fingers on the pulse of cancer drug development. In a nutshell, it looks like the world's top-selling cancer therapy could have a serious competitor. Sales of Keytruda from Merck reached $25 billion ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.5% to $116.106 on volume of 42,019,244 shares Bone Biologics Corp (BBLG) rose 83.8% to $1.47 on volume of 28,279,214 shares Zentalis Pharmaceuticals Inc. (ZNTL) rose 42.7% to $4.625 on volume of 25,143,2...